Key Takeaways
- • TPG co-managing partner Jeff Rhodes affirms that continuation vehicles (CVs) are unlikely to disappear from the private equity market because general partners recognize their structural viability and strategic value.
- • Continuation vehicles have become the dominant structure within the GP-led secondaries segment, with GP-led secondary activity expanding significantly in recent years—global GP-led secondaries volume grew from $28 billion in 2019 to $63 billion in 2021.
- • Private equity's evolution toward CVs reflects broader industry innovation, with CVs emerging as a vehicle for GPs to extend holding periods, consolidate portfolio companies, and optimize capital deployment without requiring new fund raises.
- • Strong general partners tend to launch CVs, though legacy LP participation remains limited—fewer than 6% of legacy LPs opt to roll capital into continuation vehicles, as many prefer to exit positions through secondary sales.
- • Sector specialization within the CV market, including single-asset continuation vehicles (SACVs), has accelerated as a fastest-growing segment in private equity, driven by both positive selection bias and GPs' proactive strategy of moving their best-performing companies into these structures.
Summary
Continuation vehicles have solidified their position as a permanent fixture in private equity's capital markets infrastructure rather than a cyclical phenomenon, according to TPG's co-managing partner Jeff Rhodes. In remarks to *Buyouts*, Rhodes characterized CVs as aligned with private equity's historical trajectory of structural innovation, emphasizing that general partners across the industry have demonstrated sufficient confidence in their viability to sustain their deployment across market cycles.
The data supports this assessment. Global GP-led secondaries volume—the broader market segment within which CVs operate—expanded substantially from $28 billion in 2019 to $63 billion by 2021, reflecting institutional adoption of these structures. Within that category, CVs have emerged as the dominant mechanism through which general partners extend investment horizons, consolidate portfolio company positions, and manage capital allocation between fund cycles.
While TPG has pursued CV strategies less aggressively than some competitors, the firm's leadership indicates no expectation of market retreat. This perspective reflects recognition among top-tier GPs that CVs solve specific operational and capital management problems: they enable continuation of successful portfolio companies beyond standard fund life cycles, allow GPs to build sector-specialized platforms, and provide liquidity optionality for limited partners who would otherwise face binary exit decisions.
However, the investor base for CVs remains selective. Research indicates that fewer than 6% of legacy LPs exercise rollover options into continuation vehicles, with most preferring secondary sale transactions instead. This suggests that while GPs have embraced CVs as a permanent strategic tool, LP demand remains concentrated among investors with specific long-hold mandates or those demonstrating confidence in individual GP teams.
The acceleration of single-asset continuation vehicles (SACVs) and sector-specialized CV platforms underscores the market's maturation. These structures address positive selection bias—GPs proactively transfer their highest-performing companies into dedicated vehicles—while enabling more focused operational oversight and exit strategies than traditional multi-asset fund structures permit.
The data supports this assessment. Global GP-led secondaries volume—the broader market segment within which CVs operate—expanded substantially from $28 billion in 2019 to $63 billion by 2021, reflecting institutional adoption of these structures. Within that category, CVs have emerged as the dominant mechanism through which general partners extend investment horizons, consolidate portfolio company positions, and manage capital allocation between fund cycles.
While TPG has pursued CV strategies less aggressively than some competitors, the firm's leadership indicates no expectation of market retreat. This perspective reflects recognition among top-tier GPs that CVs solve specific operational and capital management problems: they enable continuation of successful portfolio companies beyond standard fund life cycles, allow GPs to build sector-specialized platforms, and provide liquidity optionality for limited partners who would otherwise face binary exit decisions.
However, the investor base for CVs remains selective. Research indicates that fewer than 6% of legacy LPs exercise rollover options into continuation vehicles, with most preferring secondary sale transactions instead. This suggests that while GPs have embraced CVs as a permanent strategic tool, LP demand remains concentrated among investors with specific long-hold mandates or those demonstrating confidence in individual GP teams.
The acceleration of single-asset continuation vehicles (SACVs) and sector-specialized CV platforms underscores the market's maturation. These structures address positive selection bias—GPs proactively transfer their highest-performing companies into dedicated vehicles—while enabling more focused operational oversight and exit strategies than traditional multi-asset fund structures permit.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.